Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing

Overview of attention for article published in Frontiers in Pharmacology, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 1 X user

patent: 3 patents

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 5,783 followers.

New Research: Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing https://t.co/LIgYZzPNYI #pharmacology

31 Jan 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.